Shares of Braskem S.A. (NYSE:BAK - Get Free Report) have been assigned a consensus recommendation of "Reduce" from the eight brokerages that are presently covering the company, Marketbeat reports. Four investment analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation and one has given a strong buy recommendation to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $3.2750.
A number of research analysts have recently weighed in on BAK shares. Bank of America downgraded shares of Braskem from a "neutral" rating to an "underperform" rating and set a $2.80 price target on the stock. in a report on Thursday, March 26th. Citigroup raised Braskem from a "strong sell" rating to a "hold" rating in a research note on Wednesday, April 1st. Bradesco Corretora downgraded Braskem from an "outperform" rating to an "underperform" rating and set a $1.50 price objective on the stock. in a research note on Tuesday, April 21st. Weiss Ratings reissued a "sell (e+)" rating on shares of Braskem in a research note on Monday, April 20th. Finally, Zacks Research upgraded shares of Braskem from a "hold" rating to a "strong-buy" rating in a report on Monday, April 6th.
Get Our Latest Stock Report on Braskem
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of the company. Signaturefd LLC increased its position in Braskem by 50.1% in the 4th quarter. Signaturefd LLC now owns 13,524 shares of the company's stock worth $40,000 after buying an additional 4,513 shares during the period. EverSource Wealth Advisors LLC grew its stake in shares of Braskem by 444.4% in the fourth quarter. EverSource Wealth Advisors LLC now owns 8,579 shares of the company's stock worth $25,000 after acquiring an additional 7,003 shares during the last quarter. Quadrant Capital Group LLC increased its position in Braskem by 222.1% during the fourth quarter. Quadrant Capital Group LLC now owns 12,809 shares of the company's stock worth $38,000 after acquiring an additional 8,832 shares during the period. Virtu Financial LLC increased its position in Braskem by 28.7% during the third quarter. Virtu Financial LLC now owns 44,587 shares of the company's stock worth $108,000 after acquiring an additional 9,938 shares during the period. Finally, Ballentine Partners LLC bought a new position in Braskem during the third quarter worth $34,000.
Braskem Stock Performance
Shares of BAK stock opened at $3.41 on Tuesday. Braskem has a 1 year low of $2.32 and a 1 year high of $5.30. The stock has a market cap of $1.36 billion, a PE ratio of -0.74 and a beta of 1.74. The business's fifty day moving average is $3.94 and its 200-day moving average is $3.33.
Braskem (NYSE:BAK - Get Free Report) last announced its quarterly earnings data on Saturday, February 14th. The company reported ($2.33) earnings per share (EPS) for the quarter. Braskem had a negative return on equity of 21.95% and a negative net margin of 14.53%.The business had revenue of $2.56 billion during the quarter. Equities research analysts predict that Braskem will post -2 earnings per share for the current year.
Braskem Company Profile
(
Get Free Report)
Braskem NYSE: BAK is a leading integrated petrochemical company based in São Paulo, Brazil, and holds the distinction of being the largest thermoplastic resins producer in Latin America. The company operates across the entire value chain, from feedstock sourcing and polymer production to distribution and recycling. Braskem's comprehensive approach to petrochemical manufacturing enables it to serve a diverse set of end markets with a broad portfolio of products.
Braskem's core product lines include polypropylene, polyethylene and polyvinyl chloride (PVC), which are used in industries such as packaging, automotive, construction and electrical & electronics.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Braskem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Braskem wasn't on the list.
While Braskem currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.